You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
|
|---|---|
| Published in |
BMC Neuroscience, April 2012
|
| DOI | 10.1186/1471-2202-13-38 |
| Pubmed ID | |
| Authors |
Marica Carbone, Susan Duty, Marcus Rattray |
| Abstract |
Riluzole is a neuroprotective drug used in the treatment of motor neurone disease. Recent evidence suggests that riluzole can up-regulate the expression and activity of the astrocyte glutamate transporter, GLT-1. Given that regulation of glutamate transport is predicted to be neuroprotective in Parkinson's disease, we tested the effect of riluzole in parkinsonian rats which had received a unilateral 6-hydroxydopamine injection into the median forebrain bundle. |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 2% |
| Australia | 1 | 2% |
| Unknown | 57 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 15 | 25% |
| Student > Master | 11 | 19% |
| Researcher | 10 | 17% |
| Professor > Associate Professor | 5 | 8% |
| Student > Bachelor | 3 | 5% |
| Other | 10 | 17% |
| Unknown | 5 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 15 | 25% |
| Agricultural and Biological Sciences | 14 | 24% |
| Medicine and Dentistry | 8 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Other | 7 | 12% |
| Unknown | 7 | 12% |